Topical delivery of mesenchymal stem cells and their function in wounds

Stem Cell Research and Therapy

Volumn 1, Issue 4, 2010, Pages

  Sorrell, J Michael ^a   Caplan, Arnold I ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; FIBRIN; TRANSFORMING GROWTH FACTOR BETA1;

BURN; CELL FATE; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CELL TRANSFER; ENDOTHELIUM CELL; FIBROBLAST; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; SCAR FORMATION; SKIN INJURY; SKIN TRANSPLANTATION; TOPICAL DELIVERY; VASCULARIZATION; WOUND; WOUND HEALING;

CELL DIFFERENTIATION; DRUG ADMINISTRATION ROUTES; ENDOTHELIAL CELLS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; WOUND HEALING; WOUNDS AND INJURIES;

EID: 79952533299     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt30     Document Type: Review

References (55)

1. Mesenchymal stem cells as trophic mediators. Caplan AI, Dennis JE, J Cell Biochem 2006 98 1076 1084 10.1002/jcb.20886 16619257 (Pubitemid 44128350)
2. Why are MSCs therapeutic? New data: new insight. Caplan AI, J Pathol 2009 217 318 324 10.1002/path.2469 19023885
3. Heterotopic of bone marrow: analysis of precursor cells for osteogenic and hematopoietic tissues. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP, Transplantation 1968 6 230 247 10.1097/00007890-196803000-00009 5654088
4. Hemopoietic stem cell differentiation. Till JE, McCulloch EA, Biochim Biophys Acta 1980 605 431 459 7006701 (Pubitemid 11160413)
5. Mesenchymal stem cell homing: the devil is in the details. Karp JM, Teo GSL, Cell Stem Cell 2009 4 206 216 10.1016/j.stem.2009.02.001 19265660
6. Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Dash NR, Dash SN, Routray P, Mohapatra S, Mohapatra PC, Rejuvenation Res 2009 12 359 368 10.1089/rej.2009.0872 19929258
7. More insight into mesenchymal stem cells and their effects inside the body. Zou Z, Zhang Y, Hao L, Wang F, Liu D, Su Y, Sun H, Expert Opin Biol Ther 2010 10 215 230 10.1517/14712590903456011 20088716
8. Minimal criteria for defining mutipotent mesenchymal stromal cells. The International Society of Cellular Therapy position statement. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E, Cytotherapy 2006 8 315 317 10.1080/14653240600855905 16923606 (Pubitemid 44269669)
9. CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model. Lee CH, Shah B, Moioli EK, Mao JJ, J Clin Invest 2010 120 3340 3349 10.1172/JCI43230 20679726
10. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. Guilak F, Lott KE, Awad HA, Cao Q, Hicok KC, Fermor B, Gimble JM, J Cell Physiol 2006 206 229 237 10.1002/jcp.20463 16021633 (Pubitemid 41740736)
11. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Traktuev DO, Merfeld-Clauss S, Li J, Kolonin M, Arap W, Pasqualini R, Johnstone BH, March KL, Circ Res 2008 102 77 85 10.1161/CIRCRESAHA.107.159475 17967785
12. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. Zannetino ACW, Paton SAA, Khor F, Itescu S, Gimble JM, J Cell Physiol 2008 214 413 421 10.1002/jcp.21210 17654479 (Pubitemid 350308998)
13. Therapeutic potential of adipose-derived stem cells in vascular growth and tissue repair. Hong SJ, Traktuev D, March KL, Curr Opin Organ Transplant 2010 15 86 91 10.1097/MOT.0b013e328334f074 19949335
14. A perivascular origin for mesenchymal stem cells in multiple human organs. Crisan M, Yap S, Casteilla L, Chen C-W, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C, Teng P-N, Traas J, Schugar R, Deasy BM, Badylak S, Buhring H-J, Giacobino J-P, Lazzari L, Huard J, Péault B, Cell Stem Cell 2008 3 301 313 10.1016/j.stem.2008.07.003 18786417
15. Perivascular ancestors of adult multipotent stem cells. Corselli M, Chen C-W, Crisan M, Lazzari L, Péault B, Arterioscler Thromb Vasc Biol 2010 30 1104 1109 10.1161/ATVBAHA.109.191643 20453168
16. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Chamberlain G, Fox J, Ashton B, Middleton J, Stem Cells 2007 25 2739 2749 10.1634/stemcells.2007- 0197 17656645 (Pubitemid 350127858)
17. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Mitchell JB, McIntosh K, Zvonic S, Garrett S, Floyd ZE, Kloster A, Halvorsen YD, Storms RW, Goh B, Kilroy G, Wu X, Gimble JM, Stem Cells 2006 24 376 385 10.1634/stemcells.2005-0234 16322640 (Pubitemid 44464807)
18. Mesenchymal stem cells can participate in ischemic neovascularization. Hamou C, Callaghan MJ, Thangarajah H, Chang E, Chang EI, Grogan RH, Paterno J, Vial IN, Jazayeri L, Gurtner GC, Plast Reconstr Surg 2009 123 45S 55S 10.1097/PRS.0b013e318191be4a 19182663
19. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Falanga V, Iwamoto S, Chartier M, Yufit T, Butmarc J, Kouttab N, Shrayer D, Carson P, Tissue Eng 2007 13 1299 1312 10.1089/ten.2006.0278 17518741 (Pubitemid 46986730)
20. Mesenchymal stem cell therapy for nonhealing cutaneous wounds. Hanson SE, Bentz ML, Hematti P, Plast Reconstr Surg 2010 125 510 516 10.1097/PRS. 0b013e3181c722bb 20124836
21. Participation of bone marrow derived cells in cutaneous wound healing. Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P, J Cell Physiol 2003 196 245 250 10.1002/jcp.10260 12811816 (Pubitemid 36775870)
22. Wound therapy by marrow mesenchymal cell transplantation. Yoshikawa T, Mitsumo H, Nonaka I, Sen Y, Kawanishi K, Inada Y, Takakura Y, Okuchi K, Nonomura A, Plast Reconstr Surg 2008 121 860 877 10.1097/01.prs.0000299922.96006.24 18317135 (Pubitemid 351642820)
23. Promotion of incisional wound repair by human mesenchymal stem cell transplantation. Stoff NS, Moore ST, Numnum M, Espinosa-de-los-Monteros A, Richter DF, Siegal GP, Chow LT, Feldman D, Vasconez LO, Mathis JM, Stoff A, Rivera A, Banerjee A, Stoff-Khalili MA, Curiel DT, Exp Dermatol 2009 18 362 369 10.1111/j.1600-0625.2008.00792.x 18803656
24. Accelerated wound healing in healing-impaired db/db mice by autologous adipose tissue-derived stromal cells combined with atelocollagen matrix. Nambu M, Kishimoto S, Nakamura S, Mizuno H, Yanagibayashi S, Yamamoto N, Azuma R, Nakamura S-I, Kiyosawa T, Ishihara M, Kanatani Y, Ann Plast Surg 2009 62 317 321 10.1097/SAP.0b013e31817f01b6 19240532
25. Cutaneous wound healing. Singer AJ, Clark RAF, N Engl J Med 1999 341 738 746 10.1056/NEJM199909023411006 10471461 (Pubitemid 29407375)
26. Principles and practices for treatment of cutaneous wounds with cultured skin substitutes. Boyce ST, Warden MD, Am J Surg 2002 183 445 456 10.1016/S0002-9610(02)00813-9 11975935 (Pubitemid 34442512)
27. Human bone marrow-derived cells: an attractive source to populate dermal substitutes. Fioretti F, Lebreton-DeCoster C, Gueniche F, Yousfi M, Humbert P, Godeau G, Senni K, Desmoulière A, Coulomb B, Wound Repair Regen 2008 16 87 94 10.1111/j.1524-475X.2007.00304.x 18211582
28. Cultured skin substitutes: a review. Boyce ST, Tissue Eng 1996 2 255 266 10.1089/ten.1996.2.255 19877957 (Pubitemid 27036618)
29. Influence of adult mesenchymal stem cells on in vitro vascular formation. Sorrell JM, Baber MA, Caplan AI, Tissue Eng Part A 2009 15 1751 1761 10.1089/ten.tea.2008.0254 19196139
30. Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rats. McFarlin K, Gao X, Liu Y, Dulchavsky DS, Li y, Chopp M, Dulchavsky S, Gautam SC, Wound Repair Regen 2006 14 471 478 10.1111/j.1743-6109.2006.00153.x 16939576 (Pubitemid 44266605)
31. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Wu Y, Chen L, Scott PG, Tredget EE, Stem Cells 2007 25 2648 2659 10.1634/stemcells.2007-0226 17615264 (Pubitemid 47582758)
32. Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Wang J, Zhang S, Rabinovich B, Bidant L, Soghomonyan S, Alauddin MM, Bankson JA, Shpall E, Willerson JT, Gelovani JG, Yeh TH, Circ Res 2010 106 1904 1911 10.1161/CIRCRESAHA.110.221762 20448213
33. Bone marrow cells differentiate into wound myofibroblasts and accelerate the healing of wounds with exposed bones when combined with an occlusive dressing. Yamaguchi Y, Kubo T, Murakami T, Takahashi M, Hakamata Y, Kobayashi E, Yoshida S, Hosokawa K, Yoshikawa K, Itami S, Br J Dermatol 2005 152 616 622 10.1111/j.1365-2133.2005.06402.x 15840089 (Pubitemid 40571290)
34. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. da Silva Meirelles L, Fontes AM, Covas DT, Caplan AI, Cytokine Growth Factor Rev 2009 20 419 427 10.1016/j.cytogfr.2009.10.002 19926330
35. Wound repair by bone marrow stromal cells through growth factor production. Liu Y, Dulchavsky DS, Gao X, Kwon D, Chopp M, Dulchavsky S, Gautam SC, J Surg Res 2006 136 336 341 10.1016/j.jss.2006.07.037 17045612 (Pubitemid 44737852)
36. Mesenchymal stem cells induce dermal fibroblast responses to injury. Smith AN, Willis E, Chan VT, Muffley LA, Isik FF, Gibran NS, Mocking AM, Exp Cell Res 2010 316 48 54 10.1016/j.yexcr.2009.08.001 19666021
37. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Tögel F, Weiss K, Yang Y, Hu Z, Westenfelder C, Am J Physiol Renal Physiol 2007 292 1626 F1635 10.1152/ajprenal.00339.2006 17213465 (Pubitemid 46701891)
38. Use of human mesenchymal cells to improve vascularization in a mouse model for scaffold-based dermal regeneration. Egãa JT, Fierro FA, Krüger S, Bornhäuser M, Huss R, Lavandero S, Machens H-G, Tissue Eng Part A 2009 15 1191 1200 10.1089/ten.tea.2008.0097 18925832
39. Mesenchymal cells potentiate vascular endothelial growth factor-induced angiogenesis in vitro. Tille J-C, Pepper MS, Exp Cell Res 2002 280 179 191 10.1006/excr.2002.5635 12413884 (Pubitemid 35333760)
40. Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells. Gruber R, Kandler B, Holzmann P, Vögele-Kadleetz M, Losert U, Fisher MB, Watzek G, Tissue Eng 2005 11 896 903 10.1089/ten.2005.11.896 15998229 (Pubitemid 40960792)
41. Bone marrow stromal stem cells: nature, biology, and potential applications. Bianco P, Riminucci M, Gronthos S, Robey PG, Stem Cells 2001 19 180 192 10.1634/stemcells.19-3-180 11359943 (Pubitemid 32524539)
42. The bone marrow constitutes a reservoir of pericyte progenitors. Lamagna C, Bergers G, J Leukoc Biol 2006 80 677 681 10.1189/jlb.0506309 16888086 (Pubitemid 44835880)
43. All MSCs are pericytes? Caplan AI, Cell Stem Cell 2008 3 229 230 10.1016/j.stem.2008.08.008 18786406
44. Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells. Traktuev DO, Prater DN, Merfeld-Clauss S, Saneevaiah AR, Saadatzadeh MR, Murphy M, Johnstone BH, Ingram DA, March KL, Circ Res 2009 104 1410 1420 10.1161/CIRCRESAHA.108.190926 19443841
45. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Au P, Tam J, Fukumura D, Jain RK, Blood 2008 111 4551 4558 10.1182/blood-2007-10-118273 18256324
46. Endothelial-pericyte interactions in angiogenesis. Gerhardt H, Betsholtz C, Cell Tissue Res 2003 314 15 23 10.1007/s00441-003-0745-x 12883993 (Pubitemid 37409909)
47. What brings pericytes to tumor vessels? Jain RK, Booth MF, J Clin Invest 2003 112 1134 1136 14561696 (Pubitemid 38056288)
48. PDGF, TGF, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. Hirschi KK, Rohusky SA, D'Amore PA, J Cell Biol 1998 141 805 814 10.1083/jcb.141.3.805 9566978 (Pubitemid 28217923)
49. Long-term in vivo imaging of human angiogenesis: critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels. Sanz L, Santos-Valle P, Alonso-Camino V, Salas C, Serrano A, Vicario JL, Cuesta AM, Compte M, Sánchez-Martín D, Alvarez-Vallina L, Microvasc Res 2008 75 308 314 10.1016/j.mvr.2007.11.007 18252255
50. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Ghannam S, Bouffi C, Djouad F, Nol D, Stem Cell Res Ther 2010 1 2 10.1186/scrt2 20504283
51. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringden O, Scand J Immunol 2003 57 11 20 10.1046/j.1365-3083.2003.01176.x 12542793 (Pubitemid 38019084)
52. Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Beggs KJ, Lyubimov A, Borneman JN, Bartholomew A, Moseley A, Dodds R, Archambault MP, Smith AK, McIntosh KR, Cell Transplant 2006 15 711 721 10.3727/000000006783981503 17269442 (Pubitemid 46095254)
53. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R, Exp Hematol 2002 30 42 48 10.1016/S0301-472X(01)00769-X 11823036 (Pubitemid 34059216)
54. Identification of fibrocytes in postburn hypertrophic scar. Yang L, Scott PG, Dodd C, Medina A, Jiao H, Shankowsky HA, Ghahary A, Tredget EE, Wound Repair Regen 2005 13 398 404 10.1111/j.1067-1927.2005.130407.x 16008729 (Pubitemid 41060421)
55. Neutralisation of TGF-1 and TGF-2 or exogenous addition of TGF-3 to cutaneous rat wounds reduces scarring. Shah M, Foreman DM, Ferguson MWJ, J Cell Sci 1995 108 985 1002 7542672